Your browser doesn't support javascript.
loading
Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?
Reck, Martin; Kerr, Keith M; Grohé, Christian; Manegold, Christian; Pavlakis, Nick; Paz-Ares, Luis; Huber, Rudolf M; Popat, Sanjay; Thatcher, Nick; Park, Keunchil; Hilberg, Frank; Barrueco, José; Kaiser, Rolf.
Affiliation
  • Reck M; Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Kerr KM; Department of Pathology, Aberdeen University Medical School, Aberdeen Royal Infirmary, Aberdeen, Scotland.
  • Grohé C; Department of Respiratory Diseases, Evangelische Lungenklinik Berlin, Lindenberger Weg 27, Berlin, Germany.
  • Manegold C; Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
  • Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital (Sydney University), Reserve Road, St Leonards 2065, New South Wales, Australia.
  • Paz-Ares L; Medical Oncology Department, University Hospital 12 de Octubre, Complutense University, CNIO & CiberOnc, Madrid, Spain.
  • Huber RM; Division of Respiratory Medicine & Thoracic Oncology, Ludwig Maximilians University of Munich, & Thoracic Oncology Centre Munich, Member of the German Center for Lung Research (DZL CPC-M) Munich, Germany.
  • Popat S; Department of Medicine, Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Thatcher N; Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester, UK.
  • Park K; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Hilberg F; Boehringer Ingelheim RCV GmbH & Co. KG, A-1121, Vienna, Austria.
  • Barrueco J; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, CT 06877, USA.
  • Kaiser R; Boehringer Ingelheim Pharma GmbH & Co, KG, Germany & Institute of Pharmacology, Johannes Gutenberg-University Mainz, Germany.
Future Oncol ; 15(12): 1363-1383, 2019 Apr.
Article in En | MEDLINE | ID: mdl-30758227
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Patient Selection / Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Future Oncol Year: 2019 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Patient Selection / Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Future Oncol Year: 2019 Type: Article Affiliation country: Germany